Due to the frequent presence of interstitial lung disease and widespread use of immunosuppressive treatment, systemic sclerosis (SSc) patients may be considered at risk for a more severe disease course and higher mortality when they develop Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) virus infection. Therefore, with World Scleroderma Foundation endorsement, experts from different specialties including rheumatology, virology and clinical immunology gathered virtually to answer to the main practical clinical questions regarding SARS-CoV-2 infection coming from both patients and physicians. This preliminary advice is aligned with other national and international recommendations, adapted for SSc patients.

Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management / Matucci-Cerinic M., Bruni C., Allanore Y., Clementi M., Dagna L., Damjanov N.S., De Paulis A., Denton C.P., Distler O., Fox D., Furst D.E., Khanna D., Krieg T., Kuwana M., Lee E.B., Li M., Pillai S., Wang Y., Zeng X., Taliani G.. - In: ANNALS OF THE RHEUMATIC DISEASES. - ISSN 0003-4967. - ELETTRONICO. - 79:(2020), pp. S724-S726. [10.1136/annrheumdis-2020-217407]

Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management

Matucci-Cerinic M.;Bruni C.
Membro del Collaboration Group
;
Li M.
Membro del Collaboration Group
;
2020

Abstract

Due to the frequent presence of interstitial lung disease and widespread use of immunosuppressive treatment, systemic sclerosis (SSc) patients may be considered at risk for a more severe disease course and higher mortality when they develop Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) virus infection. Therefore, with World Scleroderma Foundation endorsement, experts from different specialties including rheumatology, virology and clinical immunology gathered virtually to answer to the main practical clinical questions regarding SARS-CoV-2 infection coming from both patients and physicians. This preliminary advice is aligned with other national and international recommendations, adapted for SSc patients.
2020
79
S724
S726
Goal 3: Good health and well-being for people
Matucci-Cerinic M.; Bruni C.; Allanore Y.; Clementi M.; Dagna L.; Damjanov N.S.; De Paulis A.; Denton C.P.; Distler O.; Fox D.; Furst D.E.; Khanna D.;...espandi
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1204560
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 56
  • ???jsp.display-item.citation.isi??? 50
social impact